학술논문
Long-term safety and efficacy of daclizumab beta in relapsing–remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study
Document Type
Article
Author
Source
In: Journal of Neurology . (Journal of Neurology, 1 October 2020, 267(10):2851-2864)
Subject
Language
English
ISSN
14321459
03405354
03405354